XML 25 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Note 1 - Significant Accounting Policies - Summary of Revenues (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Revenues $ 4,823 $ 5,887  
Torii Pharmaceutical Co. [Member]      
Revenues     $ 20,101
Product [Member]      
Revenues 218 1,679  
Royalty [Member]      
Revenues 1,945 2,322  
Collaborative and Other Research and Development [Member]      
Revenues 2,660 1,886  
Collaborative and Other Research and Development [Member] | US Department of Health and Human Services [Member]      
Revenues 1,607 1,886  
Collaborative and Other Research and Development [Member] | Torii Pharmaceutical Co. [Member]      
Revenues $ 1,053